Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Ezzat Elhassadi"'
Autor:
Anna Keogh, Fiona Lynott, Antonios Papanicolau-Sengos, Mutaz Mohammed Nur, Aisling Spillane, Fiona Quinn, Ezzat ElHassadi, Elaine S. Jaffe, Richard Flavin
Publikováno v:
Hematology Reports, Vol 14, Iss 4, Pp 335-341 (2022)
Nodal peripheral T cell lymphoma (PTCL) with T follicular helper (TFH) cell phenotype is a provisional entity added to the 2016 revised WHO classification of haematological malignancies. These lymphomas have an aggressive clinical course and respond
Externí odkaz:
https://doaj.org/article/0f49330a238547218a047a737e849ade
Autor:
Mark A. Catherwood, Dorte Wren, Laura Chiecchio, Doriane Cavalieri, David Donaldson, Sarah Lawless, Ezzat ElHassadi, Amjad Hayat, Mary R. Cahill, Derville O’Shea, Jeremy Sargent, Peter Stewart, Manisha Maurya, John Quinn, Philip Murphy, David Gonzalez de Castro, Ken Mills, Nicholas C. P. Cross, Francesco Forconi, Sunil Iyengar, Anna Schuh, Patrick Thornton
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Limited data exists to show the correlation of (tumour protein 53) TP53 mutation detected by Next generation sequencing (NGS) and the presence/absence of deletions of 17p13 detected by FISH. The study which is the largest series to date includes 2332
Externí odkaz:
https://doaj.org/article/f68447793d1e43bead15fecab502e322
Autor:
David Jackson, Anthony G Ryan, Elaine Walsh, Mark Bolger, Brian Hennessy, Ezzat ElHassadi, Senthil Kumar, Joan Heneghan, Donal O'Driscoll
Publikováno v:
BJR|case reports. 8
Lymphomas are a heterogenous group of cancers of the lymphatic system in which disease primarily arises in lymph nodes. Extranodal disease is common; however, musculoskeletal involvement is rare. Imaging plays an important role in the diagnosis and s
Autor:
Stephen E. Langabeer, Lisa Preston, Johanna Kelly, Matt Goodyer, Ezzat Elhassadi, Amjad Hayat
Publikováno v:
Case Reports in Hematology, Vol 2017 (2017)
Several variant RARA translocations have been reported in acute promyelocytic leukemia (APL) of which the t(11;17)(q23;q21), which results in a ZBTB16-RARA fusion, is the most widely identified and is largely resistant to therapy with all-trans retin
Externí odkaz:
https://doaj.org/article/27d507d83f304c85bf7446dc4013d132
Autor:
Ezzat Elhassadi
Publikováno v:
Annals of Clinical Oncology. :1-4
Mantle Cell Lymphoma (MCL) is a rare type of B-cell non-Hodgkin lymphoma (NHL), characterised by an aggressive clinical course and a poor prognosis that remains incurable for the majority of patients. Cyclin D1 overexpression, which results from t(11
Autor:
Ezzat Elhassadi
Publikováno v:
International Journal of Cancer Science and Therapy. :1-3
The coronavirus disease 2019 (COVID-19) pandemic has challenged our healthcare systems and threatened individuals worldwide, particularly the most vulnerable elderly and those with medical comorbidities. The emergence of the new virus variant with it
Publikováno v:
Irish Journal of Medical Science (1971 -). 190:1239-1241
Autor:
Ezzat Elhassadi
Publikováno v:
Annals of Clinical Oncology. :1-4
Mantle cell lymphoma (MCL) is a rare incurable subtype of B-cell lymphoma characterized by t(11;14)(q13;q32)-driven over expression of cyclin D1 [1]. MCL is associated with the highest degree of genomic instability of the B cell malignancies, and TP5
Autor:
Xianquan Zhan, Xiaowei Wang, Dominic M. Desiderio, John Jacob Mundukottackal, Vidhya Ravindranadan, C. Doherty, R. Ajayi, Y. Ajumobi, Ezzat Elhassadi, Kenji Sasaki, Y. M. Swarna, I. M. Ali, Rajeshwari G. Annigeri, V. Belenky, V. Golovkin, A. Stannzevsky, O. Klicenko, V. Gelman, E. Koroleva, Chaisiri Chaichankul, Jung-Hee Lee, Yukiko Ohashi, Toshinori Kitamura, Mohammad Taghi Sheykhi, Shobhana Nayak-Rao, M. Pradeep Shenoy, G. C. Onyemelukwe, D. Ogoina, G. E. Ibiam, G. H. Ogbadu, Mayuri Ahuja, Vikram Singh, Archana Mehta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c4c09e8c95697077b938c00702ecb85
https://doi.org/10.9734/bpi/ctmamr/v11
https://doi.org/10.9734/bpi/ctmamr/v11
Publikováno v:
Clinical Case Reports
Key Clinical Message CNS myelomatous involvement is a rare complication of multiple myeloma with dismal outcome. This disease's optimal treatment is unclear. Combined approach of systemic therapy, radiotherapy, and intrathecal injections chemotherapy